Research Articles | Page 6 | Aplastic Anemia & MDS International Foundation

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Allogeneic BM transplantation for the treatment of aplastic anemia: current results and expanding donor possibilities Dec 2013 Hematology Am Soc Hematol Educ Program aplastic anemia
Allogeneic haematopoietic stem cell transplantation in myelodysplastic syndromes Sep 2014 Curr Opin Oncol myelodysplastic syndromes (MDS)
Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes - Lingering Uncertainties and Emerging Possibilities Jul 2014 Biol Blood Marrow Transplant myelodysplastic syndromes (MDS)
Allogeneic hematopoietic cell transplantation for severe aplastic anemia: similar long-term overall survival after transplantation with related donors compared to unrelated donors Oct 2015 Bone Marrow Transplant aplastic anemia
Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndromes Oct 2012 Semin Hematol myelodysplastic syndromes (MDS)
Allogeneic hematopoietic stem cell transplantation for myelodysplastic syndromes Sep 2013 Clin Lymphoma Myeloma Leuk myelodysplastic syndromes (MDS)
Allogeneic hematopoietic stem cell transplantation for paroxysmal nocturnal hemoglobinuria: a retrospective single-center study Oct 2016 Hematol Oncol paroxysmal nocturnal hemoglobinuria (PNH)
Allogeneic Hematopoietic Stem Cell Transplantation is Underutilized in Older Patients with Myelodysplastic Syndromes Mar 2017 Biol Blood Marrow Transplant myelodysplastic syndromes (MDS)
ALLOGENEIC STEM CELL TRANSPLANTATION (HSCT) FOR ADULTS WITH MYELODYSPLASTIC SYNDROMES (MDS): RELEVANCE OF PRE-TRANSPLANT DISEASE STATUS. Jun 2013 Leuk Lymphoma myelodysplastic syndromes (MDS)
Allogeneic stem cell transplantation in myelodysplastic syndromes: does pretransplant clonal burden matter? Dec 2015 Curr Opin Hematol myelodysplastic syndromes (MDS)